Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Hepatitis B
Pneumococcal disease
Older adults
2022
2016
Clear all
Type of publications
Systematic reviews (SYSVAC)
(202)
Topics
Available to download in languages
Regions
Africa
(2)
Americas
(3)
Eastern Mediterranean
(1)
Europe
(1)
South-East Asia
(2)
Western Pacific
(3)
Countries
Diseases
COVID-19
(188)
Hepatitis B
(2)
Pneumococcal disease
(12)
Herpes zoster
(3)
HIV / AIDS
(1)
Human papillomavirus (HPV)
(5)
Influenza
(24)
Yellow fever
(2)
Vaccine topics
Acceptance
(15)
Administration
(31)
Coverage
(2)
Economic aspects
(1)
Efficacy/effectiveness
(75)
Ethical issues
(1)
Safety
(106)
Target population
Older adults
(202)
Adolescents
(108)
Adults
(264)
All age groups
(237)
Children
(53)
Healthcare workers
(83)
Newborn
(29)
Parents/caregivers
(21)
Pregnant women
(48)
Risk group
(1)
Travellers
(1)
Publication date
2022
(194)
2016
(8)
2024
(1)
2023
(64)
2021
(110)
2020
(58)
2019
(4)
2018
(4)
2017
(6)
2015
(5)
2014
(1)
2013
(1)
2012
(6)
2011
(1)
202 results found
2022
∙
Huang, Y. Z. Kuan, C. C.
Vaccination to reduce severe COVID-19 and mortality in COVID-19 patients: a systematic review and meta-analysis
2022
∙
Bollaerts, K. Fletcher, M. A. Suaya, J. A. Hanquet, G. Baay, M. Gessner, B. D.
Vaccine-Preventable Disease Incidence Based on Clinically, Radiologically, and Etiologically Confirmed Outcomes: Systematic Literature Review and Re-analysis of Pneumococcal Conjugate Vaccine Efficacy Trials
2022
∙
Martinez-Reviejo, R. Tejada, S. Adebanjo, G. A. R. Chello, C. Machado, M. C. Parisella, F. R. Campins, M. Tammaro, A. Rello, J.
Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2 vaccination or infection: New insights
2022
∙
Nanishi, E. Levy, O. Ozonoff, A.
Waning effectiveness of SARS-CoV-2 mRNA vaccines in older adults: a rapid review
2016
∙
Remschmidt, C. Harder, T. Wichmann, O. Bogdan, C. Falkenhorst, G.
Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: A systematic review
2016
∙
Diao, W. Q. Shen, N. Yu, P. X. Liu, B. B. He, B.
Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: A systematic review and meta-analysis of randomized trials
2016
∙
Schiffner-Rohe, J. Witt, A. Hemmerling, J. Von Eiff, C. Leverkus, F. W.
Efficacy of PPV23 in preventing pneumococcal pneumonia in adults at increased risk - A systematic review and meta-analysis
2016
∙
Yang, S. Tian, G. Cui, Y. Ding, C. Deng, M. Yu, C. Xu, K. Ren, J. Yao, J. Li, Y. Cao, Q. Chen, P. Xie, T. Wang, C. Wang, B. Mao, C. Ruan, B. Jiang, T. Li, L.
Factors influencing immunologic response to hepatitis B vaccine in adults
2016
∙
Fan, W. Chen, X. F. Shen, C. Guo, Z. R. Dong, C.
Hepatitis B vaccine response in obesity: A meta-analysis
2016
∙
Puges, M. Biscay, P. Barnetche, T. Truchetet, M. E. Richez, C. Seneschal, J. Gensous, N. Lazaro, E. Duffau, P.
Immunogenicity and impact on disease activity of influenza and pneumococcal vaccines in systemic lupus erythematosus: a systematic literature review and meta-analysis
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register